Though less medication was used by the pregnant patients than by the non-pregnant control group, inactive disease was commonly seen in pregnant RA patients, with 58–69 % of RA patients showing low disease activity (DAS28-CRP scores <3.2; Fig. 1b). This evidence concerns the gene CRP and rheumatoid arthritis.